Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison

PURPOSE: To compare visual outcomes and treatment burden between intravitreally administered aflibercept (IVT-AFL) and ranibizumab (RBZ) treat-and-extend (T&E) regimens in patients with wet age-related macular degeneration (wAMD) at 2 years. METHODS: A systematic literature review was carried ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohji, Masahito, Lanzetta, Paolo, Korobelnik, Jean-Francois, Wojciechowski, Piotr, Taieb, Vanessa, Deschaseaux, Celine, Janer, Daniel, Tuckmantel, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467478/
https://www.ncbi.nlm.nih.gov/pubmed/32222903
http://dx.doi.org/10.1007/s12325-020-01298-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467478/
https://www.ncbi.nlm.nih.gov/pubmed/32222903
http://dx.doi.org/10.1007/s12325-020-01298-x

Ejemplares similares